Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry J Blackshear

Showing results (61-70 of 175) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decayRachel L Ogilvie, Michelle Abelson, Heidi H Hau, et al.
Environmental Health Perspectives|June 11, 2011
The Environmental Polymorphism Registry: a unique resource that facilitates translational research of environmental diseasePatricia C Chulada, Enrikas Vainorius, Stavros Garantziotis, et al.
The Journal of Biological Chemistry|December 30, 2004
Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathwayJing Li, Kathleen L O'Connor, George H Greeley, et al.
Blood|March 4, 2006
Interferons limit inflammatory responses by induction of tristetraprolinInes Sauer, Barbara Schaljo, Claus Vogl, et al.
Hippocampus|March 31, 2006
Myristoylated alanine rich C kinase substrate (MARCKS) heterozygous mutant mice exhibit deficits in hippocampal mossy fiber-CA3 long-term potentiationRifat J Hussain, Deborah J Stumpo, Perry J Blackshear, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNADaniela Frasca, Ana Marie Landin, Juan P Alvarez, et al.
Molecular and Cellular Biology|March 16, 2016
Effects of Combined Tristetraprolin/Tumor Necrosis Factor Receptor Deficiency on the Splenic TranscriptomeSonika Patial, Deborah J Stumpo, W Scott Young, et al.
Nature Communications|August 13, 2025
Multivalent interactions with CCR4-NOT and PABPC1 determine mRNA repression efficiency by tristetraprolinFilip Pekovic, Wi S Lai, Joshua Corbo, et al.
Geroscience|August 3, 2023
Tristetraprolin overexpression drives hematopoietic changes in young and middle-aged mice generating dominant mitigating effects on induced inflammation in murine modelsMayuri Tanaka-Yano, Le Zong, Bongsoo Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2011
Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolinXuesong Qian, Huan Ning, Jidong Zhang, et al.
Pageof 18

Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decayRachel L Ogilvie, Michelle Abelson, Heidi H Hau, et al.
Environmental Health Perspectives|June 11, 2011
The Environmental Polymorphism Registry: a unique resource that facilitates translational research of environmental diseasePatricia C Chulada, Enrikas Vainorius, Stavros Garantziotis, et al.
The Journal of Biological Chemistry|December 30, 2004
Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathwayJing Li, Kathleen L O'Connor, George H Greeley, et al.
Blood|March 4, 2006
Interferons limit inflammatory responses by induction of tristetraprolinInes Sauer, Barbara Schaljo, Claus Vogl, et al.
Hippocampus|March 31, 2006
Myristoylated alanine rich C kinase substrate (MARCKS) heterozygous mutant mice exhibit deficits in hippocampal mossy fiber-CA3 long-term potentiationRifat J Hussain, Deborah J Stumpo, Perry J Blackshear, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNADaniela Frasca, Ana Marie Landin, Juan P Alvarez, et al.
Molecular and Cellular Biology|March 16, 2016
Effects of Combined Tristetraprolin/Tumor Necrosis Factor Receptor Deficiency on the Splenic TranscriptomeSonika Patial, Deborah J Stumpo, W Scott Young, et al.
Nature Communications|August 13, 2025
Multivalent interactions with CCR4-NOT and PABPC1 determine mRNA repression efficiency by tristetraprolinFilip Pekovic, Wi S Lai, Joshua Corbo, et al.
Geroscience|August 3, 2023
Tristetraprolin overexpression drives hematopoietic changes in young and middle-aged mice generating dominant mitigating effects on induced inflammation in murine modelsMayuri Tanaka-Yano, Le Zong, Bongsoo Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2011
Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolinXuesong Qian, Huan Ning, Jidong Zhang, et al.
Pageof 18